Enhertu 12+

Snapiot Inc

Designed for iPhone

    • Free

iPhone Screenshots

Description

Application in support of drug in clinical trials to determine safety for use in humans. Questionnaires collect signs and symptoms of response to therapeutic intervention over the period of 18 months of treatment. All data reported to study investigators. Study participants will receive notification reminders to complete their periodic questionnaires.

Access to participate in this study requires informed consent by medical personnel. Only after consenting will participants receive an invitation to access the content of this app.

snapIoT and its platforms are HIPAA, California Privacy Rights Act, and GDPR compliant.

What’s New

Version 1.7.30

iOS18 Updates and Bug-Fixes

App Privacy

The developer, Snapiot Inc, indicated that the app’s privacy practices may include handling of data as described below. For more information, see the developer’s privacy policy.

Data Linked to You

The following data may be collected and linked to your identity:

  • User Content
  • Identifiers

Privacy practices may vary based on, for example, the features you use or your age. Learn More

More By This Developer

You Might Also Like

The Cerebral Initiative
Health & Fitness
End Brain Cancer
Medical
Multiple Myeloma Manager
Medical
Chemo Brain Cognitive Research
Medical
Living Well Plus Cancer Care
Medical
CTCAE v4.0 (EN/JA) Edition
Medical